Pettee Investors Inc. Has $219,000 Stake in Dr Pepper Snapple Group, Inc (DPS)

Pettee Investors Inc. continued to hold its position in shares of Dr Pepper Snapple Group, Inc (NYSE:DPS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,400 shares of the company’s stock at the end of the second quarter. Pettee Investors Inc.’s holdings in Dr Pepper Snapple Group were worth $219,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Fundsmith LLP raised its position in shares of Dr Pepper Snapple Group by 0.5% in the first quarter. Fundsmith LLP now owns 5,329,086 shares of the company’s stock worth $521,824,000 after buying an additional 24,232 shares during the period. Pictet Asset Management Ltd. raised its position in shares of Dr Pepper Snapple Group by 15.3% in the first quarter. Pictet Asset Management Ltd. now owns 241,603 shares of the company’s stock worth $23,658,000 after buying an additional 32,008 shares during the period. Canada Pension Plan Investment Board raised its position in shares of Dr Pepper Snapple Group by 46.4% in the first quarter. Canada Pension Plan Investment Board now owns 523,028 shares of the company’s stock worth $51,215,000 after buying an additional 165,781 shares during the period. Candriam Luxembourg S.C.A. raised its position in shares of Dr Pepper Snapple Group by 13.6% in the first quarter. Candriam Luxembourg S.C.A. now owns 19,135 shares of the company’s stock worth $1,874,000 after buying an additional 2,294 shares during the period. Finally, TIAA CREF Trust Co. FSB MO raised its position in shares of Dr Pepper Snapple Group by 16.9% in the first quarter. TIAA CREF Trust Co. FSB MO now owns 14,133 shares of the company’s stock worth $1,384,000 after buying an additional 2,042 shares during the period. Institutional investors and hedge funds own 91.54% of the company’s stock.

Dr Pepper Snapple Group, Inc (DPS) traded down 0.70% during mid-day trading on Friday, hitting $91.08. 1,226,608 shares of the stock traded hands. The company has a 50-day moving average of $90.77 and a 200 day moving average of $93.17. The firm has a market capitalization of $16.55 billion, a P/E ratio of 21.84 and a beta of 0.60. Dr Pepper Snapple Group, Inc has a 1-year low of $81.05 and a 1-year high of $99.47.

Dr Pepper Snapple Group (NYSE:DPS) last announced its earnings results on Thursday, July 27th. The company reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.28 by $0.03. The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.77 billion. Dr Pepper Snapple Group had a net margin of 11.73% and a return on equity of 38.28%. Dr Pepper Snapple Group’s revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.25 EPS. On average, equities research analysts anticipate that Dr Pepper Snapple Group, Inc will post $4.63 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 5th. Shareholders of record on Thursday, September 14th will be issued a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, September 13th. This represents a $2.32 dividend on an annualized basis and a yield of 2.55%. Dr Pepper Snapple Group’s dividend payout ratio (DPR) is 55.64%.

ILLEGAL ACTIVITY WARNING: This piece was posted by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/dr-pepper-snapple-group-inc-dps-stake-held-by-pettee-investors-inc-updated.html.

DPS has been the subject of several analyst reports. BMO Capital Markets restated a “buy” rating and set a $105.00 price target on shares of Dr Pepper Snapple Group in a report on Wednesday, July 12th. Jefferies Group LLC restated a “buy” rating and set a $112.00 price target on shares of Dr Pepper Snapple Group in a report on Thursday, July 6th. Zacks Investment Research upgraded shares of Dr Pepper Snapple Group from a “hold” rating to a “buy” rating and set a $104.00 price target for the company in a report on Tuesday, June 27th. Credit Suisse Group restated a “buy” rating on shares of Dr Pepper Snapple Group in a report on Friday, June 23rd. Finally, Cowen and Company restated a “hold” rating and set a $96.00 price target on shares of Dr Pepper Snapple Group in a report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company. Dr Pepper Snapple Group has a consensus rating of “Hold” and a consensus price target of $99.64.

In other Dr Pepper Snapple Group news, insider Angela A. Stephens sold 3,160 shares of the stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $92.51, for a total value of $292,331.60. Following the completion of the transaction, the insider now owns 16,913 shares in the company, valued at $1,564,621.63. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.58% of the stock is currently owned by corporate insiders.

Dr Pepper Snapple Group Company Profile

Dr Pepper Snapple Group, Inc is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The Company offers a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

Institutional Ownership by Quarter for Dr Pepper Snapple Group (NYSE:DPS)

Receive News & Ratings for Dr Pepper Snapple Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply